SPY002

Drug identity checked against registry records

Also recorded as SPY002-091

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative ColitisNCT07012395SYREPhase 2Recruiting2027-06Estimated
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBDNCT07652294SYREPhase 2Enrolling by invitation2029-03-02Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.